Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

CONRAD receives funding for phase III microbicide trials

May 6, 2005

Novel HIV reverse transcriptase inhibitors emerge from Gilead R&D

May 5, 2005

Completion of phase I study of VRX-496 HIV gene therapy

May 4, 2005

Gilead progresses new fixed-dose combination of Truvada and Sustiva

April 29, 2005

Virax advances HIV/AIDS Co-X-Gene programs

April 29, 2005

Insmed studies SomatoKine for HIV-associated lipodystrophy

April 22, 2005

Antiviral effects of a novel nonimmunosuppressive ciclosporin analogue

April 20, 2005

First results on the efficacy and safety of EG-005 in lipodystrophy

April 20, 2005

Chemokine CCR5 modulators and their use as anti-HIV agents claimed by ViroChem and AstraZeneca

April 18, 2005

Development of a stable and effective vaginal anti-HIV microbicide

April 15, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...